Gerald M. Reaven

77.2k total citations · 16 hit papers
666 papers, 59.5k citations indexed

About

Gerald M. Reaven is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology. According to data from OpenAlex, Gerald M. Reaven has authored 666 papers receiving a total of 59.5k indexed citations (citations by other indexed papers that have themselves been cited), including 433 papers in Endocrinology, Diabetes and Metabolism, 223 papers in Molecular Biology and 194 papers in Physiology. Recurrent topics in Gerald M. Reaven's work include Diabetes, Cardiovascular Risks, and Lipoproteins (228 papers), Metabolism, Diabetes, and Cancer (181 papers) and Diet and metabolism studies (114 papers). Gerald M. Reaven is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (228 papers), Metabolism, Diabetes, and Cancer (181 papers) and Diet and metabolism studies (114 papers). Gerald M. Reaven collaborates with scholars based in United States, Taiwan and Italy. Gerald M. Reaven's co-authors include Fahim Abbasi, Jerrold M. Olefsky, John W. Farquhar, Cindy Lamendola, Tracey McLaughlin, Brian B. Hoffman, Clarie B. Hollenbeck, Francesco Facchini, Michael S. Greenfield and Lewis Landsberg and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

Gerald M. Reaven

664 papers receiving 56.0k citations

Hit Papers

Role of Insulin Resistanc... 1967 2026 1986 2006 1988 1988 1996 1995 2003 2.5k 5.0k 7.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Role of Insulin Resistance in Human Disease
    1988 9.7k citations Gerald M. Reaven profile →
  2. Banting lecture 1988. Role of insulin resistance in human disease
    1988 3.1k citations Gerald M. Reaven profile →
  3. Hypertension and Associated Metabolic Abnormalities — The Role of Insulin Resistance and the Sympathoadrenal System
    1996 1.1k citations Gerald M. Reaven et al. profile →
  4. Pathophysiology of insulin resistance in human disease
    1995 972 citations Gerald M. Reaven profile →
  5. Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant
    2003 779 citations Tracey McLaughlin, Fahim Abbasi et al. profile →
  6. Fructose-induced insulin resistance and hypertension in rats.
    1987 735 citations Gerald M. Reaven et al. profile →
  7. A new rat model of type 2 diabetes: The fat-fed, streptozotocin-treated rat
    2000 708 citations Gerald M. Reaven et al. Metabolism profile →
  8. Role of Insulin Resistance in Human Disease (Syndrome X): An Expanded Definition
    1993 673 citations Gerald M. Reaven profile →
  9. Measurement of Plasma Glucose, Free Fatty Acid, Lactate, and Insulin for 24 h in Patients With NIDDM
    1988 613 citations Gerald M. Reaven et al. profile →
  10. Impaired Nitric Oxide Synthase Pathway in Diabetes Mellitus
    2002 552 citations Gerald M. Reaven et al. profile →
  11. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles.
    1993 547 citations Gerald M. Reaven et al. profile →
  12. Is There a Simple Way to Identify Insulin-Resistant Individuals at Increased Risk of Cardiovascular Disease?
    2005 504 citations Tracey McLaughlin, Gerald M. Reaven et al. profile →
  13. Effects of Weight Reduction on Obesity STUDIES OF LIPID AND CARBOHYDRATE METABOLISM IN NORMAL AND HYPERLIPOPROTEINEMIC SUBJECTS
    1974 423 citations Jerrold M. Olefsky, Gerald M. Reaven et al. profile →
  14. Role of Insulin in Endogenous Hypertriglyceridemia*
    1967 414 citations Gerald M. Reaven et al. profile →
  15. Reappraisal of the role of insulin in hypertriglyceridemia
    1974 408 citations Jerrold M. Olefsky, Gerald M. Reaven et al. The American Journal of Medicine profile →
  16. Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes
    1970 396 citations Gerald M. Reaven et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerald M. Reaven United States 109 30.5k 19.1k 13.6k 13.4k 11.2k 666 59.5k
Steven M. Haffner United States 125 33.2k 1.1× 11.4k 0.6× 11.2k 0.8× 14.5k 1.1× 14.9k 1.3× 518 62.2k
Robert H. Eckel United States 82 22.0k 0.7× 16.8k 0.9× 8.7k 0.6× 14.4k 1.1× 14.7k 1.3× 242 65.3k
Markku Laakso Finland 117 23.4k 0.8× 13.5k 0.7× 16.3k 1.2× 9.8k 0.7× 13.0k 1.2× 673 58.2k
Steven E. Kahn United States 105 21.1k 0.7× 13.3k 0.7× 12.7k 0.9× 9.2k 0.7× 4.8k 0.4× 471 46.7k
Ronald M. Krauss United States 104 18.5k 0.6× 9.8k 0.5× 7.9k 0.6× 7.6k 0.6× 9.6k 0.9× 380 48.7k
Ele Ferrannini Italy 107 29.1k 1.0× 11.9k 0.6× 15.2k 1.1× 8.1k 0.6× 7.0k 0.6× 535 51.5k
Yūji Matsuzawa Japan 123 13.5k 0.4× 25.2k 1.3× 16.7k 1.2× 36.8k 2.7× 16.7k 1.5× 700 80.5k
Takashi Kadowaki Japan 119 14.1k 0.5× 16.3k 0.9× 25.1k 1.9× 17.1k 1.3× 7.6k 0.7× 869 62.0k
Ralph A. DeFronzo United States 113 24.6k 0.8× 17.7k 0.9× 21.0k 1.5× 9.1k 0.7× 4.3k 0.4× 427 52.3k
Coen D.A. Stehouwer Netherlands 119 15.7k 0.5× 12.4k 0.6× 6.7k 0.5× 9.9k 0.7× 17.6k 1.6× 1.1k 57.4k

Countries citing papers authored by Gerald M. Reaven

Since Specialization
Citations

This map shows the geographic impact of Gerald M. Reaven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald M. Reaven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald M. Reaven more than expected).

Fields of papers citing papers by Gerald M. Reaven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald M. Reaven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald M. Reaven. The network helps show where Gerald M. Reaven may publish in the future.

Co-authorship network of co-authors of Gerald M. Reaven

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald M. Reaven. A scholar is included among the top collaborators of Gerald M. Reaven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald M. Reaven. Gerald M. Reaven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clarke, Shoa L., Gerald M. Reaven, David Léonard, et al.. (2020). Cardiorespiratory Fitness, Body Mass Index, and Markers of Insulin Resistance in Apparently Healthy Women and Men. The American Journal of Medicine. 133(7). 825–830.e2. 15 indexed citations
2.
Ariel, Danit, Sun H. Kim, Alice Liu, et al.. (2015). Salsalate-induced changes in lipid, lipoprotein, and apoprotein concentrations in overweight or obese, insulin-resistant, nondiabetic individuals. Journal of clinical lipidology. 9(5). 658–663. 10 indexed citations
3.
Kim, Sun H., Fahim Abbasi, Cindy Lamendola, et al.. (2009). Relationship between body mass index and insulin resistance in patients treated with second generation antipsychotic agents. Journal of Psychiatric Research. 44(8). 493–498. 20 indexed citations
4.
Ardigò, Diego, Laura Franzini, Silvia Valtueña, et al.. (2009). The increase in plasma PAI-1 associated with insulin resistance may be mediated by the presence of hepatic steatosis. Atherosclerosis. 208(1). 240–245. 9 indexed citations
5.
Abbasi, Fahim, Helke M.F. Farin, Cindy Lamendola, et al.. (2008). Pioglitazone administration decreases cardiovascular disease risk factors in insulin-resistant smokers. Metabolism. 57(8). 1108–1114. 12 indexed citations
6.
Farin, Helke M.F., Fahim Abbasi, Sun H. Kim, et al.. (2006). The relationship between insulin resistance and dyslipidaemia in cigarette smokers. Diabetes Obesity and Metabolism. 9(1). 65–69. 8 indexed citations
7.
Cobin, Rhoda H., Walter Futterweit, John E. Nestler, et al.. (2005). American Association of Clinical Endocrinologists Position Statement on Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome. Endocrine Practice. 11(2). 1–10. 76 indexed citations
8.
Witteles, Ronald, et al.. (2004). Insulin resistance in idiopathic dilated cardiomyopathy. Journal of the American College of Cardiology. 44(1). 78–81. 94 indexed citations
9.
Medicherla, Satya, Partha Neogi, Maya S. Gowri, et al.. (2003). A novel peroxisome proliferator-activated gamma (PPARγ) agonist, CLX-0921, has potent antihyperglycemic activity with low adipogenic potential. Metabolism. 52(8). 1012–1018. 20 indexed citations
10.
Witteles, Ronald, et al.. (2002). High prevalence of impaired glucose metabolism in patients with idiopathic dilated cardiomyopathy. Journal of the American College of Cardiology. 39. 181–181. 1 indexed citations
11.
Abbasi, Fahim, Byron W. Brown, Cindy Lamendola, Tracey McLaughlin, & Gerald M. Reaven. (2002). Relationship between obesity, insulin resistance, and coronary heart disease risk. Journal of the American College of Cardiology. 40(5). 937–943. 445 indexed citations
12.
Cataldo, Nicholas A., Fahim Abbasi, Tracey McLaughlin, Cynthia Lamendola, & Gerald M. Reaven. (2001). Improvement in insulin sensitivity followed by ovulation and pregnancy in a woman with polycystic ovary syndrome who was treated with rosiglitazone. Fertility and Sterility. 76(5). 1057–1059. 53 indexed citations
13.
Reaven, Gerald M., et al.. (1999). Insulin Resistance. Humana Press eBooks. 20 indexed citations
14.
Reaven, Gerald M. & Ami Laws. (1999). Insulin resistance : the metabolic syndrome X. Humana Press eBooks. 49 indexed citations
15.
Sarabia, Stephen F., et al.. (1999). PPARγ Agonists Enhance Human Vascular Endothelial Adhesiveness by Increasing ICAM-1 Expression. Biochemical and Biophysical Research Communications. 263(3). 718–722. 40 indexed citations
16.
Luo, Jian, Diana M. Fort, Thomas J. Carlson, et al.. (1998). Cryptolepis sanguinolenta: an ethnobotanical approach to drug discovery and the isolation of a potentially useful new antihyperglycaemic agent. Diabetic Medicine. 15(5). 367–374. 66 indexed citations
17.
Reaven, Gerald M.. (1991). Relationship Between Insulin Resistance and Hypertension. Diabetes Care. 14(Supplement_4). 33–38. 90 indexed citations
18.
Pontremoli, Roberto, et al.. (1991). Changes in Blood Pressure, Plasma Triglyceride and Aldosterone Concentration, and Red Cell Cation Concentration in Patients With Hyperinsulinemia. American Journal of Hypertension. 4(2 Pt 1). 159–163. 4 indexed citations
19.
Bühler, Fritz R., Stevo Julius, & Gerald M. Reaven. (1990). A New Dimension in Hypertension. Journal of Cardiovascular Pharmacology. 15. S1–S3. 5 indexed citations
20.
Crapo, Phyllis A, Gerald M. Reaven, & Jerrold M. Olefsky. (1981). Hormonal and substrate responses to a standard meal in normal and hypertriglyceridemic subjects. Metabolism. 30(4). 331–334. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven M. Haffner Breakdown of academic impact, for papers by Robert H. Eckel Breakdown of academic impact, for papers by Markku Laakso Breakdown of academic impact, for papers by Steven E. Kahn Breakdown of academic impact, for papers by Ronald M. Krauss Breakdown of academic impact, for papers by Ele Ferrannini Breakdown of academic impact, for papers by Yūji Matsuzawa Breakdown of academic impact, for papers by Takashi Kadowaki Breakdown of academic impact, for papers by Ralph A. DeFronzo Breakdown of academic impact, for papers by Coen D.A. Stehouwer
Rankless by CCL
2026